What is Archimedes?
ArchimedesRx stands as a leader in specialty drug management solutions, dedicated to establishing sustainable cost controls and enhancing clinical care for high-cost specialty medications. The company directly serves employers and health plans, offering an alternative to traditional pharmacy benefit manager (PBM) models by aligning its interests with those of its clients. Through a commitment to transparency and value-based coverage, ArchimedesRx leverages advanced technology to pinpoint savings opportunities and manage specialty drug expenditures with precision. Their core mission is to reduce prescription drug costs while providing rigorous clinical management tailored to the specific requirements of specialty patients.
How much funding has Archimedes raised?
Archimedes has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Archimedes?
With its large-scale late-stage funding, Archimedes is poised to further solidify its market leadership and potentially disrupt the traditional PBM landscape. The strategic investment suggests confidence from backers in the company's innovative approach to specialty drug management and its ability to deliver significant cost savings and improved patient outcomes. Future developments are likely to focus on scaling operations, expanding client acquisition, and enhancing technological capabilities to maintain its competitive edge in the evolving healthcare market. This capital will be instrumental in driving further innovation and achieving broader market penetration.
See full Archimedes company page
